BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 10, 2003
View Archived Issues
Clinical benefits of efalizumab in plaque-type psoriasis
Read More
Good efficacy and safety profile reported for arzoxifene in hormone-sensitive breast cancer
Read More
New NK1 antagonists identified by Kyorin researchers
Read More
Novartis presents new PTP1B inhibitors in a recent patent
Read More
Spanish researchers prepare and test novel cannabinoid CB1 antagonists
Read More
Sumitomo claims TGF-beta antagonists with potential in fibrotic disorders
Read More
New EGFR inhibitors discovered at Boehringer Ingelheim
Read More
Ono claims novel prostanoid DP antagonists, their preparation and use
Read More
Pfizer scientists describe novel PPARgamma ligands and their use
Read More
Phase I trial begins for ChimeriVax-West Nile vaccine
Read More
Gene expression profiling for classifying pediatric ALL
Read More
Candidate gene for obesity located by international research team
Read More
Parkinson's disease: important genetic findings and RNAi-based drug development
Read More
Final results for phase II study of R-1549 in gastric cancer
Read More
Positive long-term data obtained for Aryplase
Read More
Rat study results for injectable sustained-release ZT-1 for Alzheimer's disease
Read More
Green light for phase I/II study of Enzo's gene vector for HIV
Read More
Guilford announces positive phase II results for Aquavan
Read More
Completion of first clinical study of Durect's postoperative pain depot product
Read More
Edaravone has beneficial effects in LPS-induced liver damage
Read More
Sativex marketing agreement extended to Canada
Read More
Shire and Noven work towards MethyPatch approval
Read More
Xcytrin evaluated in combination with Rituxan and Zevalin
Read More
Intranasal QR-435 prevents influenza infection in ferrets
Read More
Spotlight on systemic lupus erythematosus
Read More
Neuroprotective efficacy of neurosteroid in spinal cord ischemia
Read More
VP-025 prevents LPS-induced LTP impairment in rat brain
Read More